The FDA's Naughty List: What Indian Pharma Investors Need to Know
Warning letters, import alerts, and consent decrees — a complete guide to US FDA enforcement actions against Indian pharma companies, with case studies on Ranbaxy, Sun Pharma, Cipla, Lupin and more.
